"Concise industry news from the US pharmaceutical industry..."
New Account

The Magazine

Issue 4

Issue 4 E-magazine
  • Previous Issues

Sponsors

Platinum Sponsors
Gold Sponsors
Silver Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors

Blog

Where our team of guest writers discuss what they think about the current NGP US Issues.

Peter Duncan
Director of Business Development

Can digital pathology save drug development?

Peter Duncan of Definiens discusses the potential of digital pathology.
07 Jul 2010
Drug Discovery & Development
1 of 4 Previous | Next
Drug Discovery & Development

A neutral forum to enhance world health


The DIA is critical to the advancement of drug discovery. Why? DIA President Theresa Musser tells us more.

No Comments

Size Matters


How the tiny world of nanotechnology is having a big impact on the pharma industry. By Magforce Nanotechnologies AG

No Comments

ChemiScreen novel GPCR stable cell lines for calcium mobilization assay platforms


Historically, successful drugs have been discovered without an understanding of the molecular details of their mechanism of action.

No Comments

Optimizing Efficiency with Electronic Regulatory Submissions


A large generic pharmaceutical company has research, development, manufacturing and distribution operations worldwide. By Waters

No Comments

Standard Issue


NGP speaks with Professor Antony N Davies, Senior Marketing Manager, Waters Informatics about how the use of standards is a powerful enabling technology for moving information cleanly and in a compliant manner between applications.

No Comments
1 of 4 Previous | Next